Domingueti CB, Janini JBM, Paranaíba LMR, Lozano-Burgos C, Olivero P, González-Arriagada WA. Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth. Med Oral Patol Oral Cir Bucal. 2019 May 1;24 (3):e354-63.
doi:10.4317/medoral.22904
http://dx.doi.org/doi:10.4317/medoral.22904
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|
1. De
Morais EF, Mafra RP, Gonzaga AKG, De Souza DLB, Pinto LP, Da Silveira
ÉJD. Prognostic factors of oral squamous cell carcinoma
in young patients: a systematic review. Journal of Oral and Maxillofacial
Surgery. 2017;75:1555-1566. |
|
|
|
|
|
2.
Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L, et
al. Oral cavity and oropharyngeal squamous cell
carcinoma in young adults: a review of the literature. Radiology and oncology. 2014;48:1-10. |
|
|
|
|
|
3. Ali J, Sabiha B, Jan HU, Haider SA, Khan AA., Ali
SS. Genetic etiology of oral cancer. Oral oncology. 2017;70:23-28. |
|
|
|
|
|
4. Ali SA, Awan MS, Atif S, Ali N, Mirza Y.
Correlation of human papillomavirus infection and clinical parameters with
five-year survival in oral squamous cell carcinoma. The Journal of Laryngology &
Otology, 2018;132:628-635. |
|
|
|
|
|
5. Bessell A, Glenny AM, Furness S, Clarkson JE,
Oliver R, Conway DI, et al. Interventions for the treatment of oral and
oropharyngeal cancers: surgical treatment. Cochrane Database Syst Rev.
2011. |
|
|
|
|
|
6. Jerjes W, Upile T, Petrie A, Riskalla A, Hamdoon
Z, Vourvachis M, et al. Clinicopathological parameters, recurrence,
locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma
patients. Head
& neck oncology. 2010;2:9. |
|
|
|
|
|
7. Warnakulasuriya S. Global epidemiology of oral
and oropharyngeal cancer. Oral oncology. 2009;45:309-316. |
|
|
|
|
|
8. Curry JM, Sprandio J, Cognetti D, Luginbuhl A,
Bar-ad V, Pribitkin E, et al. Tumor microenvironment in head and neck
squamous cell carcinoma. In Seminars in oncology. WB Saunders. 2014;41:217-234. |
|
|
|
|
|
9.
Oliveira-Neto HH, De Souza PPC, Da Silva MRB, Mendonça EF, Silva TA, Batista
AC. The expression of chemokines CCL19, CCL21 and their
receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical
lymph node metastasis. Tumor Biology. 2013;34:65-70. |
|
|
|
|
|
10. Davidson B, Dong HP, Holth A, Berner A, Risberg
B. Chemokine receptors are infrequently expressed in malignant and benign
mesothelial cells. American journal of clinical pathology. 2007;127:752-759. |
|
|
|
|
|
11. Wilson J, Balkwill F. The role of cytokines in
the epithelial cancer microenvironment. In Seminars in cancer biology.
Academic Press. 2002;12:113-120. |
|
|
|
|
|
12. Chakraborty K, Bose A, Chakraborty T, Sarkar K,
Goswami S, Pal S, et al. Restoration of dysregulated CC chemokine signaling
for monocyte/macrophage chemotaxis in head and neck squamous cell carcinoma
patients by neem leaf glycoprotein maximizes tumor cell cytotoxicity. Cellular & molecular
immunology. 2010;7:396. |
|
|
|
|
|
13. Berlato C, Khan MN, Schioppa T, Thompson R,
Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting
microenvironment of renal cancer. The Journal of clinical investigation. 2017;127:801-813. |
|
|
|
|
|
14. Cheng S, Guo J, Yang Q, Yang X. Crk-like adapter
protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition
via ERK signaling pathway in epithelial ovarian carcinomas. Medical oncology. 2015;32:47. |
|
|
|
|
|
15.
González-Arriagada WA, Lozano-Burgos C, Zú-iga-Moreta R, González-Díaz P,
Coletta RD. Clinicopathological significance of
chemokine receptor (CCR1, CCR3, CCR4, CCR5, CCR7 and CXCR4) expression in head
and neck squamous cell carcinomas. J. Oral Pathol. Med. 2018;47:755-763. |
|
|
|
|
|
16. Lydiatt
WM, Patel SG, O'Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, et
al. Head and neck cancers-major changes in the American
Joint Committee on cancer eighth edition cancer staging manual. CA: a cancer
journal for clinicians. 2017;67:122-137. |
|
|
|
|
|
17.
Tirelli G, Gatto A, Nata FB, Bussani R, Piccinato A, Marcuzzo AV, et
al. Prognosis of oral cancer: a comparison of the
staging systems given in the 7th and 8th editions of the American Joint
Committee on Cancer Staging Manual. British Journal of Oral and Maxillofacial
Surgery. 2018;56:8-13. |
|
|
|
|
|
18. Lingen MW, Kalmar JR, Karrison T, Speight PM.
Critical evaluation of diagnostic aids for the detection of oral
cancer. Oral
oncology. 2008;44:10-22. |
|
|
|
|
|
19. Almangush A, Heikkinen I, Bakhti N, Mäkinen LK,
Kauppila JH, Pukkila M, et al. Prognostic impact of tumour-stroma ratio in
early-stage oral tongue cancers. Histopathology. 2018;72:1128-1135. |
|
|
|
|
|
20.
Zhang Y, Meng FY, Li WL, Zhou CX, Guan Z, Fan HY. Association of chemotactic factor receptor 5 gene with breast
cancer. Genet
Mol Res. 2013:12:5289-5300. |
|
|
|
|
|
21. Cambien B, Richard-Fiardo P, Karimdjee BF,
Martini V, Ferrua B, Pitard B, et al. CCL5 neutralization restricts cancer
growth and potentiates the targeting of PDGFRβ in colorectal
carcinoma. PloS
one. 2011;6:e28842. |
|
|
|
|
|
22. Singh SK, Mishra MK, Eltoum IEA, Bae S, Lillard
JW, Singh R. CCR5/CCL5 axis interaction promotes migratory and invasiveness
of pancreatic cancer cells. Scientific reports. 2018;8:1323. |
|
|
|
|
|
23. Umansky V, Blattner C, Gebhardt C, Utikal J.
CCR5 in recruitment and activation of myeloid-derived suppressor cells in
melanoma. Cancer
Immunology, Immunotherapy. 2017;66:1015-1023. |
|
|
|
|
|
24. Da
Silva JM, Dos Santos TPM, Sobral LM, Queiroz-Junior CM, Rachid MA, Proudfoot
AE, et al. Relevance of CCL3/CCR5 axis in oral carcinogenesis.
Oncotarget. 2017;8:51024. |
|
|
|
|
|
25. De Oliveira CE, Gasparoto TH, Pinheiro CR, Amôr
NG, Nogueira MRS, Kaneno R, et al. CCR5-dependent homing of T regulatory
cells to the tumor microenvironment contributes to skin squamous cell
carcinoma development. Molecular cancer therapeutics. 2017; molcanther-0341. |
|
|
|
|
|
26. Lang S, Lauffer L, Clausen C, Löhr I, Schmitt B,
Hölzel DIETER, et al. Impaired monocyte function in cancer patients:
restoration with a cyclooxygenase-2 inhibitor. The FASEB Journal. 2003;17:286-288. |
|
|
|
|
|
27. Tanabe Y, Sasaki S, Mukaida N, Baba T. Blockade
of the chemokine receptor, CCR5, reduces the growth of orthotopically injected
colon cancer cells via limiting cancerassociated fibroblast
accumulation. Oncotarget.
2016;7:48335. |
|
|
|
|
|
28. Liu
FY, Safdar J, Li ZN, Fang QG, Zhang X, Xu ZF, et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic
squamous cell carcinoma of head and neck. International journal of oncology. 2014;45:2502-2510 |
|
|
|
|
|
29.
Tutunea-Fatan E, Majumder M, Xin X, Lala PK. The role
of CCL21/CCR7 chemokine axis in breast cancer-induced
lymphangiogenesis. Molecular cancer. 2015;14:35. |
|
|
|
|
|
30. Malietzis G, Lee GH, Bernardo D, Blakemore AI,
Knight SC, Moorghen M. et al. The prognostic significance and relationship
with body composition of CCR7-positive cells in colorectal cancer. Journal of Surgical oncology.
2015;112:86-92. |
|
|
|
|
|
31.
Zhang L, Wang D, Li Y, Liu Y, Xie X, Wu Y, et al. CCL21/CCR7 axis contributed to CD133+ pancreatic cancer stem-like cell
metastasis via EMT and Erk/NF-κB pathway. PloS one. 2016;11:e0158529. |
|
|
|
|
|
32. Al Shareef H, Hiraoka SI, Tanaka N, Shogen Y,
Lee AD, Bakhshishayan S, et al. Use of NRP1, a novel biomarker, along with
VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict lymph node metastasis in
squamous cell carcinoma of the tongue. Oncology reports. 2016;36:2444-2454. |
|
|
|
|
|
33. Liu
FY, Safdar J, Li ZN, Fang QG, Zhang X, Xu ZF, et al. CCR7 regulates cell migration and invasion through JAK2/STAT3 in
metastatic squamous cell carcinoma of the head and neck. BioMed research international.
2014; 2014:415375. |
|
|
|
|
|
34. Zhen-jin Z, Peng L, Fa-yu L, Liyan S, Chang-fu
S. PKCα take part in CCR7/NF-κB autocrine signaling loop in
CCR7-positive squamous cell carcinoma of head and neck. Molecular and Cellular
Biochemistry. 2011;357:181-187. |
|
|
|
|
|
35. Yang L, Liu F, Xu Z, Guo N, Zheng X, Sun C.
Chemokine receptor 7 via proline-rich tyrosine kinase-2 upregulates the
chemotaxis and migration ability of squamous cell carcinoma of the head and
neck. Oncology
reports. 2012;28:1659-1664. |
|
|
|
|
|
36. Zhang Z, Liu F, Li Z, Wang D, Li R, Sun C. Jak3
is involved in CCR7-dependent migration and invasion in metastatic squamous
cell carcinoma of the head and neck. Oncology letters. 2017;13:3191-3197. |
|
|
|
|
|
37. Mathias RA, Gopal SK, Simpson RJ. Contribution
of cells undergoing epithelial-mesenchymal transition to the tumour
microenvironment. Journal
of proteomics. 2013;78:545-557. |
|
|
|
|
|
38. Xia X, Liu K, Zhang H, Shang Z. Correlation
between CCR 7 expression and lymph node metastatic potential of human tongue
carcinoma. Oral
diseases. 2015;21:123-131. |
|